CYLD and nasopharyngeal carcinoma: In addition to frequently mutated CYLD, this gene is down-regulated in 37 panels of NPC tumors compared to the paired normal tissues (Figure 1B); it is also down-regulated in 31 NPC tumors compared to 10 normal tissues in a publicly available microarray analysis (Figure 1C).